Astaxanthin enhances LRP1-modulated insulin sensitivity and amyloid beta clearance in an IN VITRO blood-brain barrier model
Joshua Adekunle Babalola1,2,3, Magdalena Lang2, Meekha George2, Anika Stracke2, Jelena Tadic4, Frank Madeo4, Achim Lass4, Gerd Leitinger5, Birgit Hutter-Paier3, Gerald Hoefler1 and Ute Panzenboeck2
1Diagnostic and Research Institute of Pathology, Medical University of Graz, Austria, 2Division of Immunology and Pathophysiology, Otto Loewi Research Center, Medical University of Graz, Austria; 3QPS Austria GmbH, Department Neuropharmacology; 4Institute of Molecular Biosciences, University of Graz, Graz, Austria; 5Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Medical University of Graz, Austria.